Molecular targets of [6]-gingerol: Its potential roles in cancer chemoprevention

BioFactors

Volumn 36, Issue 3, 2010, Pages 169-178

  Oyagbemi, Ademola A ^a   Saba, Adebowale B ^a   Azeez, Odunayo I ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

6 Gingerol; Carcinogenesis; Chemoprevention; Nuclear factor kappa B

Indexed keywords

6 GINGEROL; [1 (4' HYDROXY 3' METHOXYPHENYL) 5 HYDROXY 3 DECANONE]; [6]PARADOL; [6]SHOGAOL; ANTINEOPLASTIC AGENT; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; CYCLOOXYGENASE 2; CYTOCHROME C; GINGEROL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PARADOL; PROSTAGLANDIN SYNTHASE; SESQUITERPENE DERIVATIVE; SHOGAOL; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZERUMBONE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CYTOKINE RELEASE; DRUG METABOLISM; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME RELEASE; GINGER; HUMAN; INFLAMMATION; LUNG CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CATECHOLS; CHEMOPREVENTION; FATTY ALCOHOLS; HUMANS; NEOPLASMS; NF-KAPPA B;

ZINGIBER OFFICINALE;

EID: 77955724097     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.78     Document Type: Review

References (128)

1. Shukla, Y. and Singh, M. (2007) Cancer preventive properties of ginger: a brief review. Food Chem. Toxicol. 45, 683-690.
2. Surh, Y. J. (2002) Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem. Toxicol. 40, 1091-1097.
3. Zick, S. M., Djuric, Z., Ruffin, M. T., Litzinger, A. J., Normolle, D. P., Alrawi, S., Feng, M. R., and Brenner, D. E. (2008) Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol. Biomarkers Prev. 17, 1930-1936.
4. Penna, S. C., Medeiros, M. V., Aimbire, F. S., Faria-Neto, H. C., Sertié, J. A., and Lopes-Martins, R. A. (2003) Anti-inflammatory effect of the hydralcoholic extract of Zingiber officinale rhizomes on rat paw and skin oedema. Phytomedicine 10, 381-385.
5. Ojewole, J. A. (2006) Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytother. Res. 20, 764-772.
6. Grzanna, R., Lindmark, L., and Frondoza, C. G. (2005) Ginger-an herbal medicinal product with broad anti-inflammatory actions. J. Med. Food 8, 125-132.
7. Aimbire, F., Penna, S. C., Rodrigues, M., Rodrigues, K. C., Lopes-Martins, R. A., and Sertié, J. A. (2007) Effect of hydroalcoholic extract of Zingiber officinalis rhizomes on LPS-induced rat airway hyperreactivity and lung inflammation. Prostaglandins Leukot. Essent. Fatty Acids 77, 129-138.
8. Afzal, M., Al-Hadidi, D., Menon, M., Pesek, J., and Dhami, M. S. (2001) Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabol. Drug Interact. 18, 159-190.
9. Jeyakumar, S. M., Nalini, N., and Nalini, V. P. (1999) Antioxidant activity of ginger (Zingiber officinale) in rats fed a high fat diet. Med. Sci. Res. 27, 341-344.
10. Hudson, E. A., Fox, L. H., Luckett, J. C. A., and Manson, M. M. (2006) Ex vivo cancer chemoprevention research possibilities. Environ. Toxicol. Pharmacol. 21, 204-214.
11. Huang, S., DeGuzman, A., Bucana, D. C., and Fidler, I. J. (2000) Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin. Cancer Res. 6, 2573-2581.
12. Coppola, G. and Novo, S. (2007) Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events. Arch. Med. Res. 38, 479-488.
13. Nonn, L., Duong, D., and Peehl, D. M. (2007) Chemopreventive antiinflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells, Carcinogenesis 28, 1188-1196.
14. Kim, E. C., Min, J. K., Kim, T. Y., Lee, S. J., Yang, H. O., Han, S., Kim, Y. M., and Kwon, Y. G. (2005) Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 335, 300-308.
15. Rhode, J., Fogoros, S., Zick, S., Wahl, H., Griffith, K. A., Huang, J., and Liu, J. R. (2007) Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complement. Altern. Med. 20, 6882-6887.
16. Leal, P. F., Braga, M. E., Sato, D. N., Carvalho, J. E., Marques, M. O., and Meireles, M. A. (2003) Functional properties of spice extracts obtained via supercritical fluid extraction. J. Agric. Food Chem. 51, 2520-2525.
17. Shen, C. L., Hong, K. J., and Kim, S. W. (2005) Comparative effects of ginger root (Zingiber officinale Rosc.) on the production of inflammatory mediators in normal and osteoarthrotic sow chondrocytes, J. Med. Food 8, 149-153.
18. Park, Y. J., Wen, J., Bang, S., Park, S. W., and Song, S. Y. (2006) [6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med. J. 47, 688-697.
19. Manju, V. and Nalini, N. (2005) Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, post-initiation stages of 1, 2 dimethylhydrazine-induced colon cancer. Clin. Chim. Acta 358, 60-67.
20. Coussens, L. M. and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867.
21. Garg. A. and Aggarwal, B. B. (2002) Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 16, 1053-1068.
22. Bonizzi, G. and Karin, M. (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.
23. Kumar, A., Takada, Y., Boriek, M. A., and Aggarwal, B. B. (2004) Nuclear factor-kappaB: its role in health and disease. J. Mol. Med. 82, 434-448.
24. Aggarwal, B. B., Vijayalekshmi, V. R., and Sung, B. (2009) Targeting inflammatory pathways for prevention and therapy of cancer: shortterm friend, long-term foe. Clin. Cancer Res. 15, 425-430.
25. Xie, K. (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 12, 375-391.
26. Tripathi, S., Maier, K. G., Bruch, D., and Kittur, D. S. (2007) Effect of 6-gingerol on pro-inflammatory cytokine production and co-stimulatory molecule expression in murine peritoneal macrophages. J. Surg. Res. 138, 209-213.
27. Lee, H. S., Seo, E. Y., Kang, E. N., and Kim, W. K. (2008) [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J. Nutr. Biochem. 19, 313-319.
28. Lee, T. Y., Lee, K. C., Chen, S. Y., and Chang, H. H. (2009) 6-Gingerol inhibits ROS and iNOS through the suppression of PKC-alpha and NF-kappaB pathways in lipopolysaccharide-stimulated mouse macrophages. Biochem. Biophys. Res. Commun. 382, 134-139.
29. Chan, G., Boyle, J. O., Yang, E. K., Zhang, F., Sacks, P. G., Shah, J. P., Edelstein, D., Soslow, R. A., Koki, A. T., Woerner, B. M., Masferrer, J. L., and Dannenberg, A. J. (1999) Cyclooxygenase-2 expression is upregulated in squamous cell carcinoma of the head and neck. Cancer Res. 59, 991-994.
30. Grubbs, C. J., Lubet, R. A., Koki, A. T., Leahy, K. M., Masferrer, J. L., Steele, V. E., Kelloff, G. J., Hill, D. L., and Seibert, K. (2000) Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res. 60, 5599-5602.
31. Pentland, A. P., Schoggins, J. W., Scott, G. A., Khan, K. N., and Han, R. (1999) Reduction of UV-induced skin tumours in hairless mice by selective COX-2 inhibition. Carcinogenesis 20, 1939-1944.
32. Van Rees, B. P., Saukkonen, K., Ristimaki, A., Polkowski, W., Tytgat, G. N., Drillenburg, P., and Offerhaus, G. J. (2002) Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol. 196, 171-179.
33. Wesselborg, S., Bauer, M. K., Vogt, M., Schmitz, M. L., and Schulze-Osthoff, K. (1997) Activation of transcription factor NF-KB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem. 272, 12422-12429.
34. Yip-Schneider, M. T., Barnard, D. S., Billings, S. D., Cheng, L., Heilman, D. K., Lin, A., Marshall, S. J., Crowell, P. L., Marshall, M. S., and Sweeney, C. J. (2000) Cyclooxygenase-2 expression in human pancreatic adenocarcinomas, Carcinogenesis 21, 139-146.
35. Balkwill, F. and Coussens, L. M. (2004) The NF-KB protein is a key player in inflammation. It now seems that it might also activate signalling pathways, in both cancer cells and tumour-associated inflammatory cells, that promote malignancy. Nature 431, 405-406.
36. Greten, R. F. and Karin, M. (2004) The IKK/NF-κB activation pathway-a target for prevention and treatment of cancer. Cancer Lett. 206, 193-199.
37. Park, K. K., Chun, K. S., Lee, J. M., Lee, S. S., and Surh, Y. J. (1998) Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett. 129, 139-144.
38. Surh, Y. J. (2002) Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Toxicology 40, 1091-1097.
39. Mohan, S. and Eptein, J. B. (2003) Carcinogenesis and cycloogenase: the potential role of COX 2 inhibition in upper aerodigestive tract in cancer. Oral Oncol. 39, 537-546.
40. Muller-Decker, K., Neufang, G., Berger, I., Neumann, M., Marks, F., and Furstenberger, G. (2002) Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc. Natl. Acad. Sci. USA 99, 12483-12488.
41. Allport, V. C., Slater, D. M., Newton, R., and Bennett, P. R. (2000) NF-KB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol. Hum. Reprod. 6, 561-565.
42. Cao, Y. and Prescott, S. M. (2002) Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J. Cell. Physiol. 190, 279-286.
43. Chun, K. S., Keum, Y. S., Han, S. S., Song, Y. S., Kim, S. H., and Surh, Y. J. (2003) Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-KB activation. Carcinogenesis 24, 1515-1524.
44. Chun, K. S., Kim, S. H., Song, S. Y., and Surh, Y. J. (2004) Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis 25, 713-722.
45. Chun, S. K. and Surh, Y. J. (2004) Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 68, 1089-1100.
46. Coussens, L. M. and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867.
47. Aggarwal, B. B. (2004) Nuclear factor-kB: the enemy within. Cancer Cell 6, 203-208.
48. Aggarwal, B. B. (2003) Signaling pathways of TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745-756.
49. Tsujii, M. and DuBois, R. N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501.
50. Widelitz, R. B., Jiang, T. X., Lu, J., and Chuong, M. C. (2000) Beta-catenin in epithelial morphogenesis: conversion of part of avian foot scales into feather buds with a mutated beta-catenin. Dev. Biol. 219, 98-114.
51. Polakis, P. (2000) Wnt signaling and cancer. Genes Dev. 14, 1837-1851.
52. Bienz, M. (1999) APC: the plot thickens. Curr. Opin. Genet. Dev. 9, 595-603.
53. Shtutman, M., Zhurinsky, J., Simcha, I., Simcha, C., D'Amico, M., Pestell, R., and Ben-Zéev, A. (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 96, 5522-5527.
54. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. (1998) Identification of c-MYC as a target of the APC pathway Science 281, 1509-1512.
55. He, T. C., Chan, T. A., Vogelstein, B., and Kinzler, K. W. (1999) PPAR-delta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99, 335-345.
56. Soh, J. W., Lee, S. Y., and Weinstein, I. B. (2003) Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells. J. Exp. Ther. Oncol. 3, 115-126.
57. McJilton, M. A., Van Sikes, C., Wescott, G. G., Wu, D., Foreman, T. L., Gregory, C. W., Weidner, D. A., Harris Ford, O., Morgan Lasater, A., Mohler, J. L., and Terrian, D. M. (2003) Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells. Oncogene 22, 7958-7968.
58. Okhrimenko, H., Lu, W., Xiang, C., Hamburger, N., Kazimirsky, G., and Brodie, C. (2005) Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells. Cancer Res. 65, 7301-7309.
59. Verma, A. K., Wheeler, D. L., Aziz, H. M., and Manoharan, H. (2006) Protein kinase Cepsilon and development of squamous cell carcinoma, the nonmelanoma human skin cancer. Mol. Carcinog. 45, 381-388.
60. Wali, R. K., Bissonnette, M., Khare, S., Aquino, B., Niedziela, S., Sitrin, M., and Brasitus, T. A. (1996) Protein kinase C isoforms in the chemopreventive effects of a novel vitamin D3 analogue in rat colonic tumourigenesis. Gastroenterology 111, 118-126.
61. Powell, T. C. and Yin, L. (2006) Overexpression of PKCepsilon sensitizes LNCaP human prostate cancer cells to induction of apoptosis by bryostatin 1. Int. J. Cancer 118, 1572-1576.
62. Knauf, J. A., Ouyang, B., Croyle, M., Kimura, E., and Fagin, J. A. (2003) Acute expression of RET/PTC induces isozyme-specific activation and subsequent downregulation of PKCepsilon in PCCL3 thyroid cells. Oncogene 22, 6830-6838.
63. Baek, S. J., Kim, K. S., Nixon, J. B., Wilson, C. L., and Eling, T. E. (2001) Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol. Pharmacol. 59, 901-908.
64. Kim, K. S., Baek, S. J., Flake, G. P., Loftin, C. D., Calvo, F. B., and Eling, T. E. (2002) Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology 122, 1388-1398.
65. Baek, S. J., Okazaki, R., Lee, S. H., Martinez, J., Kim, J. S., Yamaguchi, K., Mishina, Y., Martin, D. W., Shoieb, A., Mcentee, M. F., and Eling, T. E. (2006) Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 131, 1553-1560.
66. Baek, S. J. and Eling, T. E. (2006) Changes in gene expression contribute to cancer prevention by COX inhibitors. Prog. Lipid Res. 45, 1-16.
67. Lee, S. H., Cekanova, M., and Baek, S. J. (2008) Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol. Carcinog. 47, 197-208.
68. Gilad, E., Wong, H. R., Zingarelli, B., Virág, L., O'Connor, M., Salzman, A. L., and Szabo, C. (1998) Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NF-kappaB activation. FASEB J. 12, 685-693.
69. Barnes, J. P. and Karin, M. (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066-1071.
70. Hatada, E. N., Nieters, A., Wulczyn, F. G., Naumann, M., Meyer, R., Nucifora, G., McKeithan, T. W., and Scheidereit, C. (1992) The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. Proc Natl Acad Sci USA 89, 2489-2493.
71. Senftleben, U. and Karin, M. (2002) The IKK/NF-kappa B pathway. Crit. Care Med. 30, S18-S26.
72. Ghosh, S. and Karin, M. (2002) Missing pieces in the NF-kappaB puzzle. Cell 109, S81-S96.
73. Karin, M. and Lin, A. (2002) NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227.
74. Pahl, H. L. (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866.
75. Wang, C. Y., Mayo, W. M., and Baldwin, A. S. Jr. (1996) TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-787.
76. Kucharczak, J., Simmons, M. J., Fan, Y., and Gelinas, C. (2003) To be, or not to be: NF-kappaB is the answer-role of Rel/NFkappaB in the regulation of apoptosis. Oncogene 22, 8961-8982.
77. Bond, M., Fabunmi, R. P., Baker, H. A., and Newby, A. C. (1998) Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 435, 29-34.
78. Novak, U., Cocks, G. B., and Hamilton, J. A. (1991) A labile repressor acts through the NFkB-like binding sites of the human urokinase gene. Nucleic Acids Res. 19, 3389-3393.
79. Rangaswami, H., Bulbule, A., and Kundu, G. C. (2004) Nuclear factorinducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. J. Biol. Chem. 279, 38921-38935.
80. Loch, T., Michalski, B., Mazurek, U., and Graniczka, M. (2001) Vascular endothelial growth factor (VEGF) and its role in neoplastic processes. Postepy Hig. Med. Dosw. 55, 257-274.
81. Chilov, D., Kukk, E., Taira, S., Jeltsch, M., Kaukonen, J., Palotie, A., Joukov, V., and Alitalo, K. (1997) Genomic organization of human and mouse genes for vascular endothelial growth factor C. J. Biol. Chem. 272, 25176-25183.
82. Huang, S., De Guzman, A., Bucana, D. C., and Fidler, I. J. (2000) Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin. Cancer Res. 6, 2573-2581.
83. Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, Y. C., and Baldwin, A. S. Jr. (2000) NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289, 2363-2366.
84. Hinz, M., Loser, P., Mathas, S., Krappmann, D., Dorken, B., and Scheidereit, C. (2001) Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 97, 2798-2807.
85. Hsia, C. Y., Cheng, S., Owyang, A. M., Dowdy, F. S., and Liou, H. C. (2002) c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int. Immunol. 14, 905-916.
86. La Rosa, F. A., Pierce, J. W., and Sonenshein, G. E. (1994) Differential regulation of the c-myc oncogene promoter by the NF-kappaB rel family of transcription factors. Mol. Cell Biol. 14, 1039-1044.
87. Yu, Q., Geng, Y., and Sicinski, P. (2001) Specific protection against breast cancers by cyclin D1 ablation. Nature 411, 1017-1021.
88. Cao, Y., Bonizzi, G., Seagroves, T. N., Greten, F. R., Johnson, R., Schmidt, E. V., and Karin, M. (2001) IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107, 763-775.
89. Haddad, J. J. (2004) Mitogen-activated protein kinases and the evolution of Alzheimer's: a revolutionary neurogenetic axis for therapeutic intervention?Prog. Neurobiol. 73, 359-377.
90. Herlaar, E. and Brown, Z. (1999) p38 MAPK signalling cascades in inflammatory disease. Mol. Med. Today 5, 439-447.
91. Chen, C. C. and Wang, J. K. (1999) p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol. Pharmacol. 55, 481-488.
92. Gutiérrez-Venegas, G., Maldonado-Frías, S., Ontiveros-Granados, A., Kawasaki-Cárdenas, P. (2005) Role of p38 in nitric oxide synthase and cyclooxygenase expression, and nitric oxide and PGE2 synthesis in human gingival fibroblasts stimulated with lipopolysaccharides. Life Sci. 77, 60-73.
93. Wang, W. H. and Wang, Z. M. (2005) Studies of commonly used traditional medicine-ginger. Zhongguo Zhong Yao Za Zhi 30, 1569-1573.
94. Jiang, S. Z., Wang, N. S., and Mi, S. Q. (2008) Plasma pharmacokinetics and tissue distribution of [6]-gingerol in rats. Biopharm. Drug Dispos. 29, 529-537.
95. Zick, S. M., Djuric, Z., Ruffin, M. T., Litzinger, A. J., Normolle, D. P., Alrawi, S., Feng, M. R., and Brenner, D. E. (2008) Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol. Biomarkers Prev. 17, 1930-1936.
96. Surh, Y. J. and Lee, S. S. (1994) Enzymic reduction of [6]-gingerol, a major pungent principle of ginger, in the cell-free preparation of rat liver. Life Sci. 54, PL321-PL326.
97. Surh, Y. J. and Lee, S. S. (1992) Enzymatic reduction of shogaol: a novel biotransformation pathway for the alpha, beta-unsaturated ketone system. Biochem. Int. 27, 179-187.
98. Wei, W., Li, C.-Y., Wen, X.-D., Li, P., and Qi, L.-W. (2009) Plasma pharmacokinetics, tissue distribution and excretion study of 6-gingerol in rat by liquid chromatography-electrospray ionization time-of-flight mass spectrometry. J. Pharm. Biomed. Anal. 49, 1070-1074.
99. Nakazawa, T. and Ohsawa, K. (2002) Metabolism of [6]-gingerol in rats. Life Sci. 70, 2165-2175.
100. Shukla, Y., Prasad, S., Tripathi, C., Singh, M., George, J., and Kalra, N. (2007) In vitro and in vivo modulation of testosterone mediated alterations in apoptosis related proteins by [6]-gingerol. Mol. Nutr. Food Res. 51, 1492-1502.
101. Nagasawa, H., Watanabe, K., and Inatomi, H. (2002) Effects of bitter melon (Momordica charantia l.) or ginger rhizome (Zingiber offifinale rosc) on spontaneous mammary tumorigenesis in SHN mice. Am. J. Chin. Med. 30, 195-205.
102. Kim, M., Miyamoto, S., Yasui, Y., Oyama, T., Murakami, A., and Tanaka, T. (2009) Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. Int. J. Cancer 124, 264-271.
103. Kim, S. O., Chun, K. S., Kundu, J. K., and Surh, Y. J. (2004) Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. Biofactors 21, 27-31.
104. Kim, E. C., Min, J. K., Kim, T. Y., Lee, S. J., Yang, H. O., Han, S., Kim, Y. M., and Kwon, Y. G. (2005) [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 335, 300-308.
105. Habib, S. H., Makpol, S., Abdul Hamid, N. A., Das, S., Ngah, W. Z., and Yusof, Y. A. (2008) Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics (Sao Paulo) 63, 807-813.
106. Yagihashi, S., Miura, Y., and Yagasaki, K. (2008) Inhibitory effect of gingerol on the proliferation and invasion of hepatoma cells in culture. Cytotechnology 57, 129-136.
107. Surh, Y. J., Park, K. K., Chun, K. S., Lee, L. J., Lee, E., and Lee, S. S. (1999) Anti-tumour-promoting activities of selected pungent phenolic substances present in ginger. J Environ Pathol Toxicol Oncol 18, 131-139.
108. Jeong, C. H., Bode, A. M., Pugliese, A., Cho, Y. Y., Kim, H. G., Shim, J. H., Jeon, Y. J., Li, H., Jiang, H., and Dong, Z. (2009) [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res. 69, 5584-5591.
109. Kim, J. S., Lee, S. I., Park, H. W., Yang, J. H., Shin, T. Y., Kim, Y. C., Baek, N. I., Kim, S. H., Choi, S. U., Kwon, B. M., Leem, K. H., Jung, Y. M., and Kim, D. K. (2008) Cytotoxic components from the dried rhizomes of Zingiber officinale Roscoe. Arch. Pharm. Res. 31, 415-418.
110. Nigam, N., George, J., Srivastava, S., Roy, P., Bhui, K., Singh, M., and Shukla, Y. (2010) Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a] P-induced mouse skin tumourigenesis. Cancer Chemother. Pharmacol. 65, 687-696.
111. Suzuki, F., Kobayashi, M., Komatsu, Y., Kato, A., and Pollard, B. R. (1997) Keishi-ka-kei-to, a traditional Chinese herbal medicine, inhibits pulmonary metastasis of B16 melanoma. Anticancer Res. 17, 873-878.
112. Yoshimi, N., Wang, A., Morishita, Y., Tanaka, T., Sugie, S., Kawai, K., Yamahara, J., and Mori, H. (1992) Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats. Jpn. J. Cancer Res. 83, 1273-1278.
113. Bode, A. M., Ma, W. Y., Surh, J. Y., and Dong, Z. (2001) Inhibition of epidermal growth factor induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res. 61, 850-853.
114. Lee, E. and Surh, Y. J. (1998) Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Lett. 134, 163-168.
115. Mahady, G. B., Pendland, S. L., Yun, G. S., Lu, Z. Z., and Stoia, A. (2003) Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer Res. 23, 3699-3702.
116. Surh, Y. J., Park, K. K., Chun, K. S., Lee, L. J., Lee, E., and Lee, S. S. (1999) Anti-tumour-promoting activities of selected pungent phenolic substances present in ginger. J. Environ. Pathol. Toxicol. Oncol. 18, 131-139.
117. Lee, E. and Surh, Y. J. (1998) Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Lett. 134, 163-168.
118. Bode, A. M., Ma, W. Y., Surh, Y. J., and Dong, Z. (2001) Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res. 61, 850-853.
119. Nurtjahja-Tjendraputra, E., Ammit, A. J., Roufogalis, B. D., Tran, V. H., and Duke, C. C. (2003) Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thromb. Res. 111, 259-265.
120. Tjendraputra, E., Tran, V. H., Liu-Brennan, D., Roufogalis, B. D., and Duke, C. C. (2001) Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg. Chem. 29, 156-163.
121. Chung, W. Y., Jung, Y. J., Surh, Y. J., Lee, S. S., and Park, K. K. (2001) Antioxidative and antitumor promoting effects of [6]-paradol and its homologs. Mutat. Res. 496, 199-206.
122. Riera, C. E., Menozzi-Smarrito, C., Affolter, M., Michlig, S., Munari, C., Robert, F., Vogel, H., Simon, S. A., and le Coutre, J. (2009) Compounds from Sichuan and Melegueta peppers activate, covalently and non-covalently, TRPA1 and TRPV1 channels. Br J Pharmacol 157, 1398-1409.
123. Ahn, S. I., Lee, J. K., and Youn, H. S. (2009) Inhibition of homodimerization of toll-like receptor 4 by 6-shogaol. Mol. Cell 27, 211-215.
124. Pan, M. H., Hsieh, M. C., Hsu, P. C., Ho, S. Y., Lai, C. S., Wu, H., Sang, S., and Ho, C. T. (2008) 6-Shogaol suppressed lipopolysaccharideinduced up-expression of iNOS and COX-2 in murine macrophages. Mol. Nutr. Food Res. 52, 1467-1477.
125. Isa, Y., Miyakawa, Y., Yanagisawa, M., Goto, T., Kang, M. S., Kawada, T., Morimitsu, Y., Kubota, K., and Tsuda, T. (2008) 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-alpha mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 373, 429-434.
126. Pan, M. H., Hsieh, M. C., Kuo, J. M., Lai, C. S., Wu, H., Sang, S., and Ho, C. T. (2008) 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol. Nutr. Food Res. 52, 527-537.
127. Chen, C. Y., Liu, T. Z., Liu, Y. W., Tseng, W. C., Liu, R. H., Lu, F. J., Lin, Y. S., Kuo, S. H., and Chen, C. H. (2007) 6-Shogaol (alkanone from ginger) induces apoptotic cell death of human hepatoma p53 mutant Mahlavu subline via an oxidative stress-mediated caspase-dependent mechanism. J. Agric. Food Chem. 55, 948-954.
128. Suekawa, M., Yuasa, K., Isono, M., Sone, H., Ikeya, Y., Sakakibara, I., Aburada, M., and Hosoya, E. (1986) Pharmacological studies on ginger. IV. Effect of (6)-shogaol on the arachidonic cascade. Nippon Yakurigaku Zasshi 88, 263-269.